Cardiotoxicity Evaluation of Tyrosine Kinase Inhibition using Human Induced Pluripotent Stem Cell-derived Healthy and Long QT Syndrome Cardiomyocytes. acbr [Internet]. 2024 Mar. 7 [cited 2026 Sep. 17];8(2):54-72. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15054